YOLFTbeta
Aino Health AB

Aino Health AB

AINO · ST · Healthcare / Health Information Services

0.196SEK-0.00 (-0.51%)

Price History

Full chart

Market Stats

Previous Close0.197
Open0.197
Day Range0.191 – 0.197
52-Week Range0.116 – 0.25
Volume12.61K
Market Cap48.69M
P/E (TTM)0.00
Forward P/E1.19
EPS0.00
Dividend Yield0.00%
Beta2.65
50-Day Avg0.2029
200-Day Avg0.1668

About

Aino Health AB (publ) engages in the development and provision of digital software-as- service platforms and consulting services focused on workplace health management and operational efficiency for organizations. It offers HealthManager, a SaaS platform that enables management to analyze absence data in real time and proactively act to minimize absenteeism. The company also provides ongoing consulting services for onboarding and implementation of HealthManager, as well as process implementation of measures to increase service throughput in the customer organization. It serves personnel managers, managers, and employees. The company was incorporated in 2016 and is based in Stockholm, Sweden.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMr. Jyrki Eklund
  • Employees18
  • HeadquartersKungsgatan 32, Stockholm, Sweden, 111 35, Sweden
  • Websitehttps://www.ainohealth.com

Leadership

  • Mr. Jyrki EklundCEO, President, MD, Acting Director of Aino Health Sweden & Germany and Director · b. 1968

Financials

Income Statement

Currency: SEK2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue17.50M22.25M5.53M19.25M20.75M25.87M24.92M23.04M19.91M23.92M23.94M26.11M
Growth (%)-+27.18%-75.14%+248.01%+7.80%+24.67%-3.70%-7.51%-13.61%+20.15%+0.09%+9.07%
Cost of Revenue2.89M3.19M1.16M2.57M1.28M1.73M1.31M1.48M2.14M20.12M2.43M30.38M
Gross Profit14.61M19.06M4.38M16.68M19.47M24.15M23.61M21.56M17.77M3.80M21.51M-4.27M
Gross Margin83.48%85.66%79.10%86.64%93.81%93.33%94.75%93.56%89.27%15.88%89.83%-16.36%
Operating Expense15.39M17.43M10.34M47.63M40.12M38.55M37.59M35.74M32.33M13.31M30.70M963.00K
Operating Income-784.00K1.63M-5.96M-30.95M-20.65M-14.41M-13.98M-14.18M-14.56M-9.51M-9.20M-5.24M
Operating Margin-4.48%7.33%-107.75%-160.76%-99.52%-55.68%-56.10%-61.53%-73.12%-39.77%-38.42%-20.05%
EBITDA-521.00K1.86M-5.48M-28.95M-18.75M-12.87M-9.95M-12.09M-12.26M-7.53M-6.21M-2.33M
EBITDA Margin-2.98%8.38%-99.11%-150.37%-90.32%-49.74%-39.95%-52.44%-61.56%-31.48%-25.94%-8.91%
Net Income-913.00K1.46M-5.99M-31.79M-22.01M-15.28M-13.17M-15.22M-14.96M-10.66M-9.91M-6.11M
Net Income Margin-5.22%6.57%-108.30%-165.13%-106.03%-59.04%-52.84%-66.05%-75.16%-44.57%-41.41%-23.40%
R&D---97.00K102.00K240.00K964.00K963.00K963.00K963.00K--
R&D as % of Total Revenue---0.50%0.49%0.93%3.87%4.18%4.84%4.03%--
Interest Expense138.00K189.00K20.00K163.00K626.00K361.00K1.29M1.30M796.00K1.09M790.00K861.00K
Interest Expense % of Total Revenue0.79%0.85%0.36%0.85%3.02%1.40%5.19%5.65%4.00%4.58%3.30%3.30%

Balance Sheet

Currency: SEK2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets5.98M9.04M63.35M31.39M38.07M29.41M33.38M19.02M17.33M13.51M9.86M9.70M
Total Liabilities5.57M7.06M10.02M9.43M8.21M14.94M17.36M16.44M19.57M14.37M10.32M16.12M
Total Equity407.00K1.98M53.33M21.96M29.86M14.47M16.02M2.58M-2.23M-851.00K-458.00K-6.42M
Cash1.17M735.00K38.89M9.29M11.54M3.04M9.00M453.00K2.16M1.44M741.00K5.81M
Total Debt3.06M2.36M1.22M895.00K1.09M367.00K1.49M1.06M659.00K164.00K170.00K8.32M
Net Debt1.89M1.63M-37.66M-8.39M-10.46M-2.67M-7.51M608.00K-1.50M-1.27M-741.00K2.52M

Cash Flow

Currency: SEK2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.17M198.00K-3.00M-25.89M-16.27M-10.78M-12.07M-8.11M-12.87M-6.26M-4.55M-2.41M
Investing Cash Flow-162.00K-146.00K1.43M-3.42M-4.85M-705.00K1.69M9.00K1.32M00-
Financing Cash Flow-276.00K-491.00K40.46M-361.00K23.25M2.93M16.38M-450.00K13.19M5.57M3.82M7.62M
Capital Expenditure165.00K146.00K234.00K1.44M4.85M705.00K000000
Free Cash Flow-1.34M52.00K-3.23M-27.32M-21.12M-11.48M-12.07M-8.11M-12.87M-6.26M-4.55M-2.41M
FCF to OCF114.09%26.26%107.80%105.55%129.82%106.54%100.00%100.00%100.00%100.00%100.00%100.00%

Earnings

Report DateFeb 17, 2017May 12, 2017Aug 25, 2017Nov 10, 2017Feb 23, 2018May 16, 2018Aug 24, 2018Nov 6, 2018Feb 19, 2019May 14, 2019Aug 12, 2019Oct 29, 2019Feb 4, 2020May 12, 2020Aug 21, 2020Oct 30, 2020Feb 2, 2021May 11, 2021Aug 17, 2021Oct 29, 2021Feb 7, 2022May 16, 2022Aug 22, 2022Nov 1, 2022Feb 10, 2023May 16, 2023Aug 15, 2023Nov 10, 2023Feb 23, 2024May 14, 2024Aug 16, 2024Nov 15, 2024Feb 21, 2025May 15, 2025Aug 14, 2025Nov 13, 2025Feb 19, 2026May 13, 2026Jun 30, 2026
EPS Estimate---------------------------------------
EPS Actual-0.79-0.81-1.28-1.37-1.29-1.09-0.87-0.88-0.19-0.18-0.27-0.17-0.20-0.20-0.25-0.15-0.10-0.13-0.11-0.18-0.14-0.10-0.09-0.07-0.10-0.07-0.06-0.03-0.05-0.03-0.02-0.01-0.02-0.00-0.00-0.01-0.02-0.01-0.01
Surprise---------------------------------------
TimingAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-

Key Statistics & Ratios

Market Cap48.69M
Enterprise Value50.39M
Trailing P/E0.00
Forward P/E1.19
Price / Sales2.07
Price / Book6.58
EPS0.00
Book Value-0.055
Revenue (TTM)23.50M
Gross Profit (TTM)5.40M
EBITDA-6.99M
Profit Margin-41.64%
Operating Margin-35.65%
Return on Equity0.00%
Return on Assets-90.46%
Shares Outstanding204.57M
Shares Float115.54M
Beta2.65
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%